This page describes pharmacological agents that may have legal restrictions, side effects, and drug interactions in your jurisdiction. Information is for educational research only — consult a clinician before considering any compound.

Browse

Neuroprotection Stack

Community Protocol

Antioxidant / Mitochondrial Support / Excitotoxicity Defense / Synaptic Repair

TYPICAL DOSE
Core: Emoxypine 125-250 mg PO daily, Dihexa 8-25 mg PO daily, Methylene Blue 0.5-2 mg/kg PO low-dose, Memantine 5-20 mg PO daily. Advanced: Coluracetam 3-20 mg PO/sublingual, ISRIB dosing protocol-dependent (limited human data).
ROUTE
CYCLE
STORAGE

Overview

What is Neuroprotection Stack?

Scientific Sean's neuroprotection protocol — a layered stack targeting the five mechanistic pillars of neurodegeneration: oxidative stress, excitotoxicity, neuro-inflammation, mitochondrial dysfunction, and impaired plasticity. Core tier (4 compounds): Emoxypine Succinate, Dihexa, Methylene Blue, Memantine. Advanced tier (2 compounds, Sean-flagged as 'more advanced'): Coluracetam, ISRIB. Goal isn't 'feels good for the brain' — it's preserving neuronal resilience and protecting cognitive function long-term. Everything is RUO (Research Use Only).

Key Benefits

Reduction in neuro-inflammation and oxidative stress (Emoxypine + Methylene Blue antioxidant axis), excitotoxicity defense via NMDA modulation (Memantine), enhanced synaptogenesis and dendritic spine density for memory/learning (Dihexa), mitochondrial efficiency and ATP preservation in brain regions (Methylene Blue + Emoxypine), and integrated stress response repair (ISRIB advanced tier). Cholinergic preservation rounds out the picture (Coluracetam advanced tier).

Mechanism of Action

Multi-mechanism convergence on neuronal preservation. Emoxypine Succinate provides broad antioxidant + GABA-modulatory + mitochondrial support — the all-in-one anchor. Dihexa enhances synaptogenesis, dendritic spine density, and long-term potentiation (BBB-permeable, long half-life). Methylene Blue acts as alternative electron carrier between NADH and Cytochrome C (bypassing damaged mitochondrial complexes), keeping ATP production smooth while reducing electron leakage. Memantine is a voltage-dependent NMDA antagonist — blocks excessive glutamate ONLY when receptors are overactivated, preventing excitotoxicity and calcium overload without shutting down normal plasticity. Advanced tier: Coluracetam enhances high-affinity choline uptake (HACU), sustaining acetylcholine synthesis and cholinergic function. ISRIB rescues neurons from stress-induced shutdown by inhibiting eIF2α-driven integrated stress response, restoring protein synthesis needed for repair.

What to Expect

  • Week 1
    Tolerability and dose-response.
  • Week 2-4
    Early effect window.
  • Week 4-8
    Peak benefit assessment.
  • Week 8+
    Cycle decision point.
Was this helpful?
Your feedback shapes what we research deeper.

How was your experience with this compound?

Anonymous · one vote per session · results below at 5+ votes.

Loading…

See something off?

Most of this wiki is AI-generated. Suggest a correction, dosing update, or new evidence — we review every submission.

Discussion — click to load
Loading…
Continue: Extended research →
Our verdict, decision matrix, deep dives, controversies, sources